VRD
({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid
Find entries where: VRD
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid |
Synonyms | Varespladib |
Identifiers | 2-[2-ethyl-3-oxamoyl-1-(phenylmethyl)indol-4-yl]oxyethanoic acid |
Formula | C21 H20 N2 O5 |
Molecular Weight | 380.394 |
Type | NON-POLYMER |
Isomeric SMILES | CCc1c(c2c(n1Cc3ccccc3)cccc2OCC(=O)O)C(=O)C(=O)N |
InChI | InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) |
InChIKey | BHLXTPHDSZUFHR-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 48 |
Chiral Atom Count | 0 |
Bond Count | 50 |
Aromatic Bond Count | 16 |
Drug Info: DrugBank
DrugBank ID | DB11909 |
---|---|
Name | Varespladib |
Groups | investigational |
Description | Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome. |
Synonyms |
|
Categories |
|
CAS number | 172732-68-2 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL148674 |
PubChem | 155815 |
ChEMBL | CHEMBL148674 |